Seed Biotech, Inc.

Seed Biotech, Inc. Seed Biotech Inc., a Tennessee Corporation, is a biological material derived product manufacturer. Seed Biotech, Inc.

was created for the purpose of pioneering
advanced research, development, production, and effective use of intelligently designed biological material based products. Seed Biotech, Inc.’s proprietary decellularization process has been shown to preserve the native extracellular matrix (ECM) and noncellular constituents such as the basement membrane, fibrous proteins, and non-fibrous proteins, glycosaminoglycans and proteoglycans.

https://www.seedbiotech.com/blog/2024/12/30/thank-you-for-a-successful-2024
12/30/2024

https://www.seedbiotech.com/blog/2024/12/30/thank-you-for-a-successful-2024

As we wrap up the year, Seed Biotech, Inc. extends our sincere appreciation to our physicians and strategic partners for their support throughout 2024. Your dedication and collaboration have been instrumental in advancing our mission and driving meaningful progress. We look forward to building on t

Seed Biotech® was created for the purpose of pioneering advanced research, development, production, distribution, and ef...
12/28/2023

Seed Biotech® was created for the purpose of pioneering advanced research, development, production, distribution, and effective use of intelligently designed biological material based products. Process and product designs encompass defined competitive advantage features through the use and integration of numerous core system technologies. Contact us now for more info on our allograft products!

What makes us different? Consistent with our mission to prioritize clinical convenience, practicality, and effectiveness...
12/01/2023

What makes us different?

Consistent with our mission to prioritize clinical convenience, practicality, and effectiveness, there were numerous considerations incorporated into the design of our product lines. From the packaging it is stored in, to the shape it is configured in, it all relates to optimizing its suitability for use and potential for clinical benefit. But, FIRST AND FOREMOST, our products were developed with design requirements for safety, and products provided are verified to satisfy these requirements.

Petil™ is a room temperature stable acellular allograft derived from human placental tissue collected from consenting do...
11/15/2023

Petil™ is a room temperature stable acellular allograft derived from human placental tissue collected from consenting donors. Post-decellularization and stabilization, Petil™ is packaged in a double pouch packaging system and subjected to low dose gamma irradiation. Petil™ is an acellular particulate human placental connective tissue matrix intended to replace or supplement damaged or inadequate integumental tissue. Petil™ is an allograft tissue intended for homologous use regulated by 21 CFR Part 1271 and Section 361 of the PHS Act.

Aril® is a room temperature stable allograft derived from human placental tissue collected from consenting donors. Post-...
10/17/2023

Aril® is a room temperature stable allograft derived from human placental tissue collected from consenting donors. Post-decellularization & stabilization, Aril® is packaged in a double pouch packaging system and subjected to low dose gamma irradiation. Aril® is an allograft tissue intended for homologous use regulated by 21 CFR Part 1271 and Section 361 of the PHS Act.

For more info contact us at [email protected]

Petil™ is a room temperature stable acellular allograft derived from human placental tissue collected from consenting do...
08/24/2023

Petil™ is a room temperature stable acellular allograft derived from human placental tissue collected from consenting donors. Post-decellularization and stabilization, Petil™ is packaged in a double pouch packaging system and subjected to low dose gamma irradiation. Petil™ is an acellular particulate human placental connective tissue matrix intended to replace or supplement damaged or inadequate integumental tissue. Petil™ is an allograft tissue intended for homologous use regulated by 21 CFR Part 1271 and Section 361 of the PHS Act.

Consistent with our mission to prioritize clinical convenience, practicality, and effectiveness, there were numerous con...
08/08/2023

Consistent with our mission to prioritize clinical convenience, practicality, and effectiveness, there were numerous considerations incorporated into the design of our product lines. From the packaging it is stored in, to the shape it is configured in, it all relates to optimizing its suitability for use and potential for clinical benefit. But, FIRST AND FOREMOST, our products were developed with design requirements for safety, and products provided are verified to satisfy these requirements.

Link is in our bio for more information.

Aril® is configured as a precision cut single layer of amnion shaped as an ellipse or disc. The configuration was select...
07/25/2023

Aril® is configured as a precision cut single layer of amnion shaped as an ellipse or disc. The configuration was selected and designed to maximize clinical usable surface area and limit necessary pre-operative manipulation of the graft. Seed Biotech, Inc. has shown a greater than 95% reduction in DNA using their proprietary decellularization process. As a single layer of amnion, it is not necessary to emboss Aril® as there is no side-specific orientation to the graft.

Address

701 Cherry Street, 200
Chattanooga, TN
37402

Opening Hours

Monday 9am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Telephone

(972) 707-7940

Alerts

Be the first to know and let us send you an email when Seed Biotech, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share